This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2006;35(5):405-7.

doi: 10.1159/000097697.

Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII

Takatoshi Koyama¹, Toshikage Nagao, Hidefumi Tsunozaki, Morio Arai, Osamu Miura

Affiliations

PMID: 17230044
DOI: 10.1159/000097697

Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII

Takatoshi Koyama et al. Pathophysiol Haemost Thromb. 2006.

. 2006;35(5):405-7.

doi: 10.1159/000097697.

Authors

Takatoshi Koyama¹, Toshikage Nagao, Hidefumi Tsunozaki, Morio Arai, Osamu Miura

Affiliation

¹ Department of Hematology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan. koyama.lmg@tmd.ac.jp

PMID: 17230044
DOI: 10.1159/000097697

No abstract available

PubMed Disclaimer

Similar articles

Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
Franchini M, Capra F, Capelli C, de Maria E, Lippi G, Gandini G. Franchini M, et al. Haematologica. 2001 Apr;86(4):E12. Haematologica. 2001. PMID: 11325664 No abstract available.
Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
Conesa V, Mompel A, Lopez F, Marín F, Ruiz J, Navarro F, Gomez A. Conesa V, et al. Am J Hematol. 2002 Aug;70(4):329-30. doi: 10.1002/ajh.10125. Am J Hematol. 2002. PMID: 12210816 No abstract available.
Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Guerin V, Chossat I, Dutronc H, Dubreuil M, Valentin F. Guerin V, et al. Am J Hematol. 2002 Aug;70(4):333. doi: 10.1002/ajh.10164. Am J Hematol. 2002. PMID: 12210820 No abstract available.
Experiences with recombinant factor VIIa in haemophiliacs.
Hedner U. Hedner U. Curr Stud Hematol Blood Transfus. 1991;(58):63-8. doi: 10.1159/000419339. Curr Stud Hematol Blood Transfus. 1991. PMID: 1954776 Review. No abstract available.
Transfusion medicine service policies for recombinant factor VIIa administration.
Goodnough LT, Lublin DM, Zhang L, Despotis G, Eby C. Goodnough LT, et al. Transfusion. 2004 Sep;44(9):1325-31. doi: 10.1111/j.1537-2995.2004.04052.x. Transfusion. 2004. PMID: 15318856 Review.

See all similar articles

Cited by

The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors.
Castaman G. Castaman G. Blood Transfus. 2017 Sep;15(5):478-486. doi: 10.2450/2017.0369-16. Epub 2017 May 16. Blood Transfus. 2017. PMID: 28686157 Free PMC article. Review.
Two-incision laparoscopic appendectomy for a severe hemophilia A child patient with coagulation factor VII deficiency: Case report and review of literature.
He JP, Feng JX. He JP, et al. Medicine (Baltimore). 2017 Oct;96(41):e8197. doi: 10.1097/MD.0000000000008197. Medicine (Baltimore). 2017. PMID: 29019885 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal